Prax investors have opportunity to join praxis precision medicines, inc. fraud investigation with the schall law firm

Los angeles , aug. 14, 2025 /prnewswire/ -- the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of praxis precision medicines, inc. ("praxis" or "the company") (nasdaq: prax) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
PRAX Ratings Summary
PRAX Quant Ranking